Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2021

Balance Sheet Components

Schedule of inventory

	December 31,
(in thousands)	2021		2020
Raw Material	$	1,248	$	1,321
Work in Process		2,760		1,026
Finished Goods		892		435
Inventory	$	4,900	$	2,782

Schedule of property and equipment

	December 31,
(in thousands)	2021		2020
Land	$	396	$	396
Lab equipment		424		418
Clinical equipment		65		65
Software		63		63
Total property and equipment at cost		948		942
Accumulated depreciation		(298)		(265)
Property and equipment, net	$	650	$	677

Schedule of intangible assets

	December 31,
(in thousands)	2021		2020
Developed technology	$	25,000	$	25,000
Accumulated developed technology amortization		(7,361)		(5,694)
Developed technology, net		17,639		19,306
In-process research and development		4,800		4,800
In process research and development, net		4,800		4,800
Trademarks		300		300
Accumulated trademark amortization		(88)		(69)
Trademarks, net		212		231
Total intangible assets, net	$	22,651	$	24,337

Schedule of estimated future amortization expense of intangible assets with finite lives

(in thousands)	Amounts
2022	$	1,687
2023		1,687
2024		1,687
2025		1,687
2026		1,687
Thereafter		9,416
	$	17,851

Schedule of accrued expenses

	December 31,
(in thousands)	2021		2020
Accrued interest	$	3,456	$	696
Accrued legal costs		414		291
Accrued chargebacks and discounts		335		736
Accrued local tax		285		—
Accrued vacation		281		277
Accrued distributor services fees		250		1,314
Accrued audit and tax services		167		70
Accrued payroll and commission		120		43
Accrued payroll tax		58		57
Accrued consulting		47		31
Accrued other		1,704		978
Total	$	7,117	$	4,493